Shaw, K. L., Sokolic, R., Davila, A., Silvin, C., Garabedian, E., de Oliveira, S., … Kohn, D. B. (2014). Phase II Clinical Trial of Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA-SCID). In MOLECULAR THERAPY (Vol. 22, pp. S107–S107). Washington, DC: NATURE PUBLISHING GROUP.

Shaw, Kit L., Robert Sokolic, Alejandra Davila, Christopher Silvin, Elizabeth Garabedian, Satiro de Oliveira, Provaboti Barman, et al. “Phase II Clinical Trial of Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA-SCID).” In MOLECULAR THERAPY, 22:S107–S107. NATURE PUBLISHING GROUP, 2014.

Shaw KL, Sokolic R, Davila A, Silvin C, Garabedian E, de Oliveira S, et al. Phase II Clinical Trial of Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA-SCID). In: MOLECULAR THERAPY. NATURE PUBLISHING GROUP; 2014. p. S107–S107.

Shaw, Kit L., et al. “Phase II Clinical Trial of Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA-SCID).” MOLECULAR THERAPY, vol. 22, NATURE PUBLISHING GROUP, 2014, pp. S107–S107.

Shaw KL, Sokolic R, Davila A, Silvin C, Garabedian E, de Oliveira S, Barman P, Brown B, Carbonaro D, Geiger S, Mishra S, Smogorzewska M, Jagadeesh J, Hershfield MS, Wayne A, Crooks GM, Moore T, Candotti F, Kohn DB. Phase II Clinical Trial of Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA-SCID). MOLECULAR THERAPY. NATURE PUBLISHING GROUP; 2014. p. S107–S107.